Cargando…
Revisiting IDO and its value as a predictive marker for anti-PD-1 resistance
Botticelli et al. proposed the activity of indoleamine-2,3-dioxygenase 1 (IDO) as a potential mechanism and predictive marker for primary resistance against anti-PD-1 treatment in the context of non-small cell lung cancer. However, there are a few points for the authors to address in order to streng...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339344/ https://www.ncbi.nlm.nih.gov/pubmed/30658666 http://dx.doi.org/10.1186/s12967-019-1784-8 |